African
Journals Online
East and Central African
Journal of Pharmaceutical Sciences
Volume 5 No.1 April 2002
ISSN 1026-552X
ABSTRACTS
Knowledge of Sexually
Transmitted Diseases Management Among Pharmacists in Dar es Salaam Tanzania: A
Case Study
M. Justin-Temu1*, R. Majura1, F. Damian1,
K.I.J. Pallangyo2 And E.F. Lyamuya2
1Faculty
of Pharmacy, Muhimbili University College of Health Sciences, University of Dar
es Salaam, P.O. Box 65013, Dar es Salaam
Tanzania.
2Faculty of Medicine, Muhimbili University College of
Health Sciences, University of Dar es Salaam, P.O. Box 65010, Dar es Salaam
Tanzania.
Abstract
This
study was conducted to find out if pharmacists are conversant with the
management of sexually transmitted diseases (STDs) and whether they use their
knowledge appropriately in managing their clients with STDs syndromes. A
comparison was made between community pharmacists who graduated before and
after the introduction of STDs/HIV management program in the Faculty of Pharmacy,
University of Dar es Salaam, Tanzania in 1992. The aim was also to find out if
these pharmacists have attended any training on STDs management after their
formal training, and whether they are able to make correct diagnosis and give
the right drug(s) to their clients suffering from STDs. Self-administered
questionnaires were distributed to eighty-seven pharmacists operating in Dar es
Salaam. The response was 74.7% (n=65), with female to male ratio of 1:1.8. Of
the responding pharmacists, 73.8% reported to have had formal training on STDs
management during their undergraduate course. All pharmacists reported that
they normally see clients at their pharmacies with complaints suggestive of
STDs. All pharmacists were able to list three or more STDs. About 65% of
post-curricula pharmacists were able to list one or more STDs causative agents.
Ninety four and hundred percent of pre- and post-curricular pharmacists,
respectively were found to give the right drug(s) for various STDs. Twenty
seven percent post- and 64.7% pre-curricula pharmacists had attended training
on STDs management since they graduated.
Liquid Chromatographic
Separation of Isoniazid, Pyrazinamide and Rifampicin on a Reversed-Phase Silica
Column
G.N. Thoithi1*, I.O. Kibwage1,
O. King’ondu1 And J. Hoogmartens2
1 Department of
Pharmaceutical Chemistry, Faculty of Pharmacy, University of Nairobi,
P. O. Box 19676, Nairobi. Kenya.
2Laboratorium voor
Farmaceutische Chemie en Analyse van Geneesmiddelen, Faculteit Farmaceutische
Wetenschappen, Katholieke Universiteit Leuven. E. Van Evenstraat 4, 3000
Leuven. Belgium.
Abstract
A gradient liquid
chromatographic method which can separate isoniazid, pyrazinamide and
rifampicin is described. A Hypersil C18, 5 mm, 250 mm x 4.6 mm internal
diameter column was maintained at 40°C. The method was developed by systematic
evaluation of the influence of the buffer concentration, column temperature and
the mobile phase pH. The method proposed uses isocratic elution with potassium
phosphate buffer (pH 6.0; 0.05 M) for 10 min, followed by linear gradient to
potassium phosphate buffer (pH 6.0; 0.05 M)-methanol (40:60, v/v) in 5 min,
isocratic elution at the same composition for a further 15 min and then linear
gradient back to potassium phosphate buffer (pH 6.0; 0.05 M) in 5 min. The
flow-rate was 1 ml/min and UV detection was at 254 nm. The method was validated
and it has been used for routine analysis of tablets containing isoniazid,
pyrazinamide and rifampicin. Analysis time is 35 minutes.
The Antimalarial and Antimicrobial Activity and Brine Shrimp Toxicity
of Clematis Brachiata Extracts
F.A. Okalebo1*, H.A. Rabah1, A.N. Guantai1,
C.K. Maitai1, I.O. Kibwage2, J.W. Mwangi1 and
W. Masengo1
1Department of Pharmacology and Pharmacognosy,
University of Nairobi, P. O. Box 19676, Nairobi, Kenya.
2Department of Pharmaceutical Chemistry, University
of Nairobi, P. O. Box 19676, Nairobi, Kenya.
The in vitro
antimalarial activity of the root extract in partly supports the ethnobotanical
use of the plant to manage malaria. Clematis
brachiata Thunberg (Ranunculaceae) is used in Kenya for the management of
headaches, malaria and other febrile illnesses, abdominal disorders, yaws and
for skin disorders. Old stems and leaves are chewed for the management of
toothaches and sore throats. Extracts of the plant were subjected to tests for
antimalarial, antibacterial and antifungal activity. The toxicity of the
extracts was assessed using the brine shrimp lethality bioassay. The root
extract gave the highest in vitro antimalarial activity against the
mulitidrug resistant strain, Plasmodium
falciparum VI/S (IC50=39.24 mg/ml). The stem
and leaf extracts had insignificant antiplasmodial activity. The leaf, stem and
root extracts had no bacterial or fungal inhibitory effects even at very high
concentrations of 10 mg/ml. The LD50 values of the stem and leaf
methanol extracts against the brine shrimp larvae was 365.60 and 66.5 mg/ml,
respectively.
Perception on the Use of
Sulfadoxine-Pyrimethamine Tablets in the Treatment of Uncomplicated Malaria in
Adult Malaria Patients Residing in Dar es Salaam
V. Mugoyela1*,
R. David1 And O.M.S. Minzi2
1 Department of
Medicinal Chemistry, Faculty of Pharmacy, Muhimbili University College of
Health Sciences (MUCHS), P.O Box 65013, Dar
es Salaam, Tanzania.
2 Department of
Clinical Pharmacology, Faculty of Medicine, Muhimbili University College of
Health Sciences, P.O Box 65010, Dar es
Salaam, Tanzania.
A prospective study on assessment of perceived efficacy and side effects
of sulfadoxine-pyrimethamine (SP) tablets in two hundred and twenty eight adult
malaria patients in Dar es Salaam region was carried out shortly before the
drug was introduced as a first line treatment for malaria in Tanzania. Sources
and dispensing practices with SP in the private community pharmacies were also
assessed. The study revealed that 80.3% of the patients were relieved from
malaria symptoms and 19.7% did not feel any relief after using the drug.
Further, the results showed that 39.5% of the patients did not experience side effects
while 60.5% experienced them. Among the affected respondents 25.4% suffered
from body malaise, 21.0% had diarrhoea, and 29.7% experienced nausea, vomiting
and loss of appetite, 17.4% suffered headache and abdominal discomfort and 6.5%
experienced inflammation of the lips. The results revealed that 60% of the
patients obtained SP drugs from private community pharmacies without
prescriptions while 40% obtained the drug with prescriptions. 83.2% of the
patients obtained SP from them community pharmacies, 13.9% from government
hospital pharmacies and 2.9% from home leftover medicine reserves.
|